TC Biopharm (Holdings) Plc
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, develops immunotherapy products based on its allogeneic gamma delta T cell platform in the United States. Its product pipeline comprises OmnImmune (TCB002), an allogeneic unmodified gamma-delta T cell therapy product which is in phase 2/3 clinical trial for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodifie… Read more
Market Cap & Net Worth: TC Biopharm (Holdings) Plc (TCBWF)
TC Biopharm (Holdings) Plc (PINK:TCBWF) has a market capitalization of $25.76 ($25.76) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #25076 globally and #8590 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TC Biopharm (Holdings) Plc's stock price $0.00 by its total outstanding shares 9908 (9.91K).
TC Biopharm (Holdings) Plc Market Cap History: 2025 to 2025
TC Biopharm (Holdings) Plc's market capitalization history from 2025 to 2025. Data shows growth from $25.76 to $25.76 (0.00% CAGR).
TC Biopharm (Holdings) Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TC Biopharm (Holdings) Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TCBWF by Market Capitalization
Companies near TC Biopharm (Holdings) Plc in the global market cap rankings as of March 19, 2026.
Key companies related to TC Biopharm (Holdings) Plc by market ranking:
- Teladan Setia Group Bhd (KLSE:0230): Ranked #25067 globally with a market cap of $21.93 Million USD ( RM98.77 Million MYR).
- Veracruz Properties SOCIMI SA (MC:YVCP): Ranked #25068 globally with a market cap of $21.92 Million USD ( €21.36 Million EUR).
- Kokuyo Camlin Limited (NSE:KOKUYOCMLN): Ranked #25077 globally with a market cap of $21.86 Million USD ( ₹1.89 Billion INR).
- Bayu Buana Tbk (JK:BAYU): Ranked #25078 globally with a market cap of $21.86 Million USD ( Rp355.67 Billion IDR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #25067 | Teladan Setia Group Bhd | KLSE:0230 | $21.93 Million | RM0.83 |
| #25068 | Veracruz Properties SOCIMI SA | MC:YVCP | $21.92 Million | €31.80 |
| #25077 | Kokuyo Camlin Limited | NSE:KOKUYOCMLN | $21.86 Million | ₹78.27 |
| #25078 | Bayu Buana Tbk | JK:BAYU | $21.86 Million | Rp1400.00 |
TC Biopharm (Holdings) Plc Historical Marketcap From 2025 to 2025
Between 2025 and today, TC Biopharm (Holdings) Plc's market cap moved from $25.76 to $ 25.76, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $25.76 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of TC Biopharm (Holdings) Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $25.76 USD |
| MoneyControl | $25.76 USD |
| MarketWatch | $25.76 USD |
| marketcap.company | $25.76 USD |
| Reuters | $25.76 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.